137 related articles for article (PubMed ID: 35132546)
21. As-Needed Prescribing and Administration of Psychotropic Medications in Assisted Living: A 7-State Study.
Carder P; Zimmerman S; Wretman CJ; Preisser JS; Dys S; Sloane PD
J Am Med Dir Assoc; 2022 Jun; 23(6):1038-1044.e3. PubMed ID: 34919835
[TBL] [Abstract][Full Text] [Related]
22. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
23. Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes.
Stevenson DG; O'Malley AJ; Dusetzina SB; Mitchell SL; Zarowitz BJ; Chernew ME; Newhouse JP; Huskamp HA
J Am Geriatr Soc; 2014 Sep; 62(9):1666-74. PubMed ID: 25123044
[TBL] [Abstract][Full Text] [Related]
24. Psychotropic, Anticonvulsant, and Opioid Use in Assisted Living Residents Before and During the COVID-19 Pandemic.
Maxwell CJ; Dampf H; Alkabbani W; Cotton CA; Gamble JM; Hogan DB; Gruneir A; McArthur E; Youngson E; Hsu Z; Hoben M
J Am Med Dir Assoc; 2024 Jan; 25(1):121-129. PubMed ID: 37863111
[TBL] [Abstract][Full Text] [Related]
25. Opioid and CNS-Depressant Medication Prescribing among Older Adults Enrolled in Medicare Advantage Versus Fee-for-Service Medicare.
Lei L; Bynum JP; Maust DT
Am J Geriatr Psychiatry; 2022 Feb; 30(2):249-255. PubMed ID: 34565660
[TBL] [Abstract][Full Text] [Related]
26. Psychotropic use in community residential care facilities: A prospective cohort study.
Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
[TBL] [Abstract][Full Text] [Related]
27. Psychoactive medication use among older community-dwelling Americans.
Haddad YK; Luo F; Karani MV; Marcum ZA; Lee R
J Am Pharm Assoc (2003); 2019; 59(5):686-690. PubMed ID: 31204201
[TBL] [Abstract][Full Text] [Related]
28. Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden.
Zahirovic I; Torisson G; Wattmo C; Londos E
BMC Geriatr; 2018 Feb; 18(1):50. PubMed ID: 29454305
[TBL] [Abstract][Full Text] [Related]
29. Psychotropic medications in older people in residential care facilities and associations with quality of life: a cross-sectional study.
Harrison SL; Bradley C; Milte R; Liu E; Kouladjian O'Donnell L; Hilmer SN; Crotty M
BMC Geriatr; 2018 Feb; 18(1):60. PubMed ID: 29478410
[TBL] [Abstract][Full Text] [Related]
30. To What Extent Do Local Nursing Home Prescribing Patterns Relate to Psychotropic Prescribing in Assisted Living?
Thomas KS; Wretman CJ; Sloane PD; Carder P; Schwartz L; Beeber AS; Zimmerman S
J Am Med Dir Assoc; 2021 Sep; 22(9):1813-1818.e3. PubMed ID: 33382990
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.
Gerlach LB; Kales HC; Kim HM; Zhang L; Strominger J; Covinsky K; Teno J; Bynum JPW; Maust DT
J Am Geriatr Soc; 2021 Jun; 69(6):1479-1489. PubMed ID: 33683703
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes.
Gerlach LB; Maust DT; Kales HC; Chang M; Kim HM; Wiechers IR; Zivin K
Am J Psychiatry; 2022 Aug; 179(8):544-552. PubMed ID: 35615813
[TBL] [Abstract][Full Text] [Related]
33. A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use.
Crentsil V; Ricks MO; Xue QL; Fried LP
Am J Geriatr Pharmacother; 2010 Jun; 8(3):215-24. PubMed ID: 20624611
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts.
Richter T; Mann E; Meyer G; Haastert B; Köpke S
J Am Med Dir Assoc; 2012 Feb; 13(2):187.e7-187.e13. PubMed ID: 21549645
[TBL] [Abstract][Full Text] [Related]
35. The impact of high-risk medications on mortality risk among older adults with polypharmacy: evidence from the English Longitudinal Study of Ageing.
Huang YT; Steptoe A; Wei L; Zaninotto P
BMC Med; 2021 Dec; 19(1):321. PubMed ID: 34911547
[TBL] [Abstract][Full Text] [Related]
36. Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study.
Shmagel A; Ngo L; Ensrud K; Foley R
J Pain; 2018 Oct; 19(10):1104-1112. PubMed ID: 29678564
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic medicine prescribing and polypharmacy for people with dementia entering residential aged care: the influence of changing general practitioners.
Welberry HJ; Jorm LR; Schaffer AL; Barbieri S; Hsu B; Harris MF; Hall J; Brodaty H
Med J Aust; 2021 Aug; 215(3):130-136. PubMed ID: 34198357
[TBL] [Abstract][Full Text] [Related]
38. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
[TBL] [Abstract][Full Text] [Related]
39. Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia.
Bae-Shaaw YH; Shier V; Sood N; Seabury SA; Joyce G
J Alzheimers Dis; 2023; 93(2):471-481. PubMed ID: 37038818
[TBL] [Abstract][Full Text] [Related]
40. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
